SCHEMBL7225213

SCHEMBL7225213

O=C(CCCCO)c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.44
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNH2 Q12809 8/20 0.43
MAPK1 P28482 1/20 0.43
CYP2D6 P10635 2/20 0.42
ADORA2A P29274 5/20 0.40
ADORA1 P30542 5/20 0.40
ADORA3 P0DMS8 2/20 0.40
ADORA2B P29275 1/20 0.40
CYP2C19 P33261 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NR1I2 O75469 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7219638 0.96 CYP3A4 (0.45) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL11289917 0.81 CYP2D6 (0.46) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL7075474 0.79 EIF4A1 (0.49) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL8553165 0.79 CYP2D6 (0.46) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL7225209 0.79 KCNH2 (0.43) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL7221372 0.76 CYP2D6 (0.46) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL8556340 0.76 KCNH2 (0.45) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL7219634 0.76 CYP2D6 (0.43) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL7227252 0.75 CYP2D6 (0.64) CYP3A4MAPTSMN1; SMN2HTTMEN1
SCHEMBL22645629 0.74 KCNH2 (0.49) CYP3A4MAPTSMN1; SMN2HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583156-B1 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol VERNALIS RESEARCH LIMITED (GB) 2003-06-24 US disclosed